MGRX: Mangoceuticals Inc. Market Cap to Revenue

Brandmark of MangoRx (MGRX)

The development of Mangoceuticals, Inc. (MGRX) is based on MangoRx brand recognition and the optimization of customer acquisition costs. The current P/S ratio reflects the dynamics of these processes, with 10.70 serving as the current metric level. The model is diversified through subscriptions for men's health medications. Steady growth in user loyalty and trust in the service's confidentiality strengthen the brand's modern image.

MGRX mangorx.com Market Cap to Revenue (04/28/2023 - 11/13/2026)

Analytical breakdowns for Mangoceuticals, Inc. (MGRX)

- current quotes and average value forecast:
Market Price mangorx.com|MGRX - Analyst Consensus Forecast
- market capitalization information:
Market Valuation MangoRx|MGRX - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Mangoceuticals|MGRX - Company Net Assets|Market Capitalization to Book Value Ratio mangorx.com|MGRX - Cumulative Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Capital Mangoceuticals, Inc.|MGRX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient mangorx.com|MGRX - Company Aggregate Debts|Debt to Book Value MangoRx|MGRX - Company Long-Term Debts|Company Short-Term Debts Mangoceuticals|Quick Liquidity mangorx.com
- earnings and multiples data:
MGRX - Company Net Income|Company Profit Forecast Mangoceuticals, Inc.|MGRX - Price to Earnings Ratio|Future Price to Earnings Multiple mangorx.com|MGRX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio MangoRx|MGRX - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Mangoceuticals|MGRX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months mangorx.com|MGRX - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Mangoceuticals, Inc.
- sales revenue and business income indicators:
MGRX - Company Revenue|Company Future Sales Volume mangorx.com|MGRX - P/S Multiple|Projected Price to Revenue MangoRx
General company analysis:MGRX (Mangoceuticals Inc.)
Brand item of Mangoceuticals Inc.

Aggressive marketing by Mangoceuticals, Inc. (MGRX) and a liquidity shortage make revenue a key indicator of business viability. This metric is calculated as the ratio of market capitalization to annual sales volume, determining the cost of a single dollar of revenue. Through this coefficient, an investor assesses the extent of overpayment for the asset relative to its operational efficiency. Analyzing the price/sales ratio allows for the identification of market bubbles and the avoidance of capital freezes.

Competing companies

HIMS - Price to Sales|P/S Multiple HNGE (Hinge Health)|TDOC - Market Cap to Revenue|Talkspace Corp - P/S Multiple|Price to Sales LifeMD, Inc.|AMWL (American Well) - Market Cap to Revenue|mydario.com (DRIO) - P/S Multiple|Market Cap to Revenue VSEE|MNDR (Mobile-health Network Solutions Inc) - Market Cap to Sales Volume|P/S Multiple ACCD|Price-to-Revenue Coefficient Biotricity Inc|P/S Multiple LYT (Lytus Technologies)|OTRK - Market Cap to Revenue|SHL Telemedicine, Ltd. - P/S Multiple|THRN - P/S Multiple